This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Sept. 23, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Edwards Lifesciences Corporation. ("Edwards Lifesciences" or the "Company") (NYSE: EW). Such investors are advised to contact
Robert S. Willoughby at
email@example.com or 888-476-6529, ext. 237.
The investigation concerns whether the Company issued false and/or misleading statements and failed to disclose material facts related to the prospects, projected sales and adoption of the Company's Edwards SAPIEN transcatheter aortic heart valve, including the related transfemoral and transapical delivery methods ("SAPIEN"), and related projections of financial performance for the Company's operations. On
April 23, 2013, the Company disclosed that approximately 20 candidate hospitals had postponed SAPIEN training, that there was substantially no backlog of patients awaiting SAPIEN implants, and that the Company's financial results had been and would likely continue to be weaker than estimates. In response to this news, Edwards Lifesciences' stock price fell
$18.21 per share, or 21.99 percent, to close at
$64.60 per share on
April 24, 2013 on extremely heavy trading volume.
The Pomerantz Firm, with offices in
San Diego and
Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late
Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See
CONTACT:Robert S. WilloughbyPomerantz Grossman Hufford Dahlstrom & Gross LLP
Pomerantz Grossman Hufford Dahlstrom & Gross LLP